India's weight-loss drug boom - and the risks behind it
Summary
In India, there is a rapid increase in the use of weight-loss drugs, originally developed for diabetes, now being used for weight management. These drugs, like semaglutide and tirzepatide, are popular but raise concerns about potential misuse and side effects. Medical professionals emphasize the need for lifestyle changes in addition to medication.Key Facts
- India's market for anti-obesity drugs has increased over six times in five years.
- Young professionals in urban areas are increasingly seeking weight-loss drugs.
- Semaglutide and tirzepatide are the main drugs used, initially developed to treat diabetes.
- These drugs work by making people feel full longer, reducing appetite and cravings.
- They are self-injected once a week, usually starting with a low dose.
- Doctors warn that weight can return after stopping the drugs, if not combined with diet and exercise.
- Possible side effects include nausea, diarrhea, and more severe risks like pancreatitis.
- There is a risk of muscle loss without proper nutrition or exercise, especially given common high-carb diets in India.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.